Kimberly L. Blackwell
M.D.
Chief Medical Officer
👥Biography 个人简介
Kimberly Blackwell is a breast cancer expert who has transitioned from academia to lead precision medicine initiatives in industry. At Tempus, she applies AI and real-world data to improve cancer care. Her academic work at Duke advanced understanding of HER2 biology and mechanisms of treatment resistance.
Kimberly Blackwell是乳腺癌专家，已从学术界转型领导行业精准医学倡议。在Tempus，她应用AI和真实世界数据来改善癌症护理。她在杜克的学术工作推进了对HER2生物学和治疗耐药机制的理解。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
HER2 Biology
Advanced understanding of HER2 signaling and therapeutic targeting.
Real-World Data
Applying AI and real-world evidence to precision oncology.
Representative Works 代表性著作
Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer
Journal of Clinical Oncology (2010)
Dual HER2 blockade in trastuzumab-resistant disease.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Kimberly L. Blackwell 的研究动态
Follow Kimberly L. Blackwell's research updates
留下邮箱，当我们发布与 Kimberly L. Blackwell（Tempus）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment